Additionally, during liver processing, glutathione helps counteract secondary free radicals, further reducing oxidative stress
It is not approved for human consumption, therapeutic use, or diagnostic procedures
The key finding of much less weight loss in the new trial with Type 2 diabetes helps us understand the story of GLP-1s success its not just because of reduced body weight
For the treatment of obesity, GLP-1RAs and GIP/ GLP-1RAs are indicated in patients with a body mass index (BMI) 30 kg m 2 , or 27 kg m 2 in the presence of at least one weight-related comorbidity, to support weight reduction [23]
The primary endpoint is a renal composite episode defined by a decrease in GFR 50%, end-stage renal failure, and death from a renal-cause or cardiovascular-caused death, and it is scheduled for completion in 2024